Argollo, Marjorie http://orcid.org/0000-0001-9867-8861
Kotze, Paulo Gustavo http://orcid.org/0000-0002-9632-6691
Kakkadasam, Pradeep
D’Haens, Geert
Article History
Accepted: 20 July 2020
First Online: 2 September 2020
Competing interests
: G.H. has served as an adviser for Abbvie, Ablynx, Allergan, Alphabiomics, Amakem, Amgen, AM Pharma, Arena Pharmaceuticals, AstraZeneca, Avaxia, Biogen, Bristol Meyers Squibb, Boehringer Ingelheim, Celgene/Receptos, Celltrion, Cosmo, Echo Pharmaceuticals, Eli Lilly, Engene, Ferring, DrFALK Pharma, Galapagos, Genentech/Roche, Gilead, Glaxo Smith Kline, Gossamerbio, Hospira/Pfizer, Immunic, Johnson and Johnson, Kintai Therapeutics, Lycera, Medimetrics, Millenium/Takeda, Medtronics, Mitsubishi Pharma, Merck Sharp Dome, Mundipharma, Nextbiotics, Novonordisk, Otsuka, Pfizer/Hospira, Photopill, Prodigest, Prometheus laboratories/Nestle, Progenity, Protagonist, RedHill, Robarts Clinical Trials, Salix, Samsung Bioepis, Sandoz, Seres/Nestle, Setpoint, Shire, Teva, Tigenix, Tillotts, Topivert, Versant and Vifor, and has received speaker fees from Abbvie, Biogen, Ferring, Johnson and Johnson, Merck Sharp Dome, Mundipharma, Norgine, Pfizer, Samsung Bioepis, Shire, Millenium/Takeda, Tillotts and Vifor. M.A. has served as a speaker and consultant and is on advisory boards for Abbvie, Janssen, Takeda and Pfizer. P.G.K. has received speaking fees and consultancy for Abbvie, Janssen, Takeda, Pfizer and UCB. P.K. declares no competing interests.